Morpholino (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Morpholino" in French language version.

refsWebsite

Global rank French rank

22nih.gov

4^th place

12^th place

2doi.org

2^nd place

3^rd place

1aacrjournals.org

8,869^th place

4,895^th place

1clinicaltrials.gov

5,225^th place

6,624^th place

aacrjournals.org

clincancerres.aacrjournals.org

(en) Devi GR, Beer TM, Corless CL, Arora V, Weller DL, Iversen PL, « In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors », Clin. Cancer Res., vol. 11, n^o 10,‎ 2005, p. 3930-8 (PMID 15897595, lire en ligne)

clinicaltrials.gov

« Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients - Full Text View - ClinicalTrials.gov », sur clinicaltrials.gov (consulté le 13 août 2020).

doi.org

dx.doi.org

(en) J Summerton, « Morpholino Antisense Oligomers: The Case for an RNase-H Independent Structural Type. », Biochim. Biophys. Acta, Gene Struct. Expression, vol. 1489,‎ 1999, p. 141-58 (DOI 10.1016/S0167-4781(99)00150-5)
(en) JE Summerton, « Endo-porter: a novel reagent for safe, effective delivery of substances into cells. », Ann N Y Acad Sci., vol. 1058,‎ 2005, p. 62–75 (PMID 16394126, DOI 10.1196/annals.1359.012)

nih.gov

ncbi.nlm.nih.gov

(en) BW Draper, « Inhibition of zebrafish fgf8 pre-mRNA splicing with morpholino oligos: A quantifiable method for gene knockdown. », Genesis, vol. 30, n^o 3,‎ 2001, p. 154-6 (lire en ligne [Pubmed])
(en) Heasman J, « Morpholino oligos: making sense of antisense? », Dev. Biol., vol. 243, n^o 2,‎ 2002, p. 209-14 (PMID 11884031)
Geller BL, « Antibacterial antisense », Curr. Opin. Mol. Ther., vol. 7, n^o 2,‎ 2005, p. 109-13 (PMID 15844617)
(en) TS Deas, « In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus. », Antimicrob Agents Chemother.,‎ 2007, Epub ahead of print (lire en ligne [Pubmed])
(en) G McClorey, « Induced dystrophin exon skipping in human muscle explants. », Neuromuscul Disord., vol. 16, n^os 9-10,‎ 2006, p. 583-90 (lire en ligne [Pubmed])
(en) J Summerton, « Morpholino Antisense Oligomers: Design, Preparation and Properties. », Antisense & Nucleic Acid Drug Development, vol. 7*,‎ 1997, p. 187-95 (lire en ligne [Pubmed])
(en) PA Morcos, « Achieving efficient delivery of morpholino oligos in cultured cells. », Genesis, vol. 30, n^o 3,‎ 2001, p. 94-102 (lire en ligne [Pubmed])
(en) A Nasevicius, « Effective targeted gene 'knockdown' in zebrafish. », Nature Genetics, vol. 26, n^o 2,‎ 2000, p. 216 - 20 (lire en ligne [Pubmed])
(en) J Heasman, « Beta-catenin signaling activity dissected in the early Xenopus embryo: a novel antisense approach. », Developmental Biology, vol. 222,‎ 2000, p. 124-34 (lire en ligne [Pubmed])
(en) R Kos, « The winged-helix transcription factor FoxD3 is important for establishing the neural crest lineage and repressing melanogenesis in avian embryos. », Development, vol. 128, n^o 8,‎ 2001, p. 1467-79 (lire en ligne [Pubmed])
(en) EW Howard, « SpKrl: a direct target of (beta)-catenin regulation required for endoderm differentiation in sea urchin embryos. », Development, vol. 128, n^o 3,‎ 2001, p. 365-75 (lire en ligne [Pubmed])
(en) JE Summerton, « Endo-porter: a novel reagent for safe, effective delivery of substances into cells. », Ann N Y Acad Sci., vol. 1058,‎ 2005, p. 62–75 (PMID 16394126, DOI 10.1196/annals.1359.012)
(en) SA Coonrod, « A morpholino phenocopy of the mouse MOS mutation. », Genesis, vol. 30, n^o 3,‎ 2001, p. 198-200 (lire en ligne [Pubmed])
(en) Devi GR, Beer TM, Corless CL, Arora V, Weller DL, Iversen PL, « In vivo bioavailability and pharmacokinetics of a c-MYC antisense phosphorodiamidate morpholino oligomer, AVI-4126, in solid tumors », Clin. Cancer Res., vol. 11, n^o 10,‎ 2005, p. 3930-8 (PMID 15897595, lire en ligne)
Voir figure 1 dans (en) I. Stancheva, « A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos. », Mol Cell, vol. 12, n^o 2,‎ 2003, p. 425-35 (lire en ligne [Pubmed]).
(en) IG Bruno, « Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements. », Hum Mol Genet, vol. 3, n^o 20,‎ 2004, p. 2409-20 (lire en ligne [Pubmed])
(en) F Vetrini, « Aberrant splicing in the ocular albinism type 1 gene (OA1/GPR143) is corrected in vitro by morpholino antisense oligonucleotides. », Hum Mutat, vol. 27, n^o 5,‎ 2006, p. 420-6 (lire en ligne [Pubmed])
(en) PA Morcos, « Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos. », Biochemical and Biophysical Research Communications,‎ 2007 (lire en ligne [Pubmed])
(en) WP Kloosterman, « Substrate requirements for let-7 function in the developing zebrafish embryo. », Nucleic Acids Res, vol. 32, n^o 21,‎ 2004, p. 6284-91 (lire en ligne [Pubmed])
(en) L Yen, « Exogenous control of mammalian gene expression through modulation of RNA self-cleavage. », Nature, vol. 431, n^o 7007,‎ 2004, p. 471-6 (lire en ligne [Pubmed])
(en) N Matter, « Targeted 'knockdown' of spliceosome function in mammalian cells. », Nucleic Acids Res, vol. 33, n^o 4,‎ 2005, e41 (lire en ligne [Pubmed])
(en) MT Howard, « Efficient stimulation of site-specific ribosome frameshifting by antisense oligonucleotides. », RNA, vol. 10, n^o 10,‎ 2004, p. 1653-61 (lire en ligne [Pubmed])